Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Maarten Albersen, Matthias Heck et al.|European Urology Oncology|2020Cited by 50
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Frontiers in Oncology|2023Cited by 8
Does presence of bone metastases portend worsened prognosis in metastatic renal cell carcinoma? Analysis of the REMARCC (Registry of MetAstatic RCC) database.Aaron Bradshaw, Ithaar Derweesh, Maria Carmen Mir et al.|Journal of Clinical Oncology|2020Cited by 1
Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.Margaret Meagher, Ithaar Derweesh, Ricardo Autorino et al.|Journal of Clinical Oncology|2020Cited by 1
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective studyM.C. Mir, Andrea Minervini, Riccardo Campi et al.|European Urology Supplements|2019Cited by 0